One more reason to fund the Global Fund

Slides:

Advertisements

Similar presentations

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

Advertisements

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics

The Fall of Oil Prices and the Effects on Biofuels Fernando H. Reboredo, Fernando Lidon, Fernanda Pessoa, José C. Ramalho Trends in Biotechnology Volume.

Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages (January 2010) DOI:

Recognizing Protein-Ligand Binding Sites by Global Structural Alignment and Local Geometry Refinement Ambrish Roy, Yang Zhang Structure Volume 20, Issue.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Food systems, nutrition, health and the environment

Dizziness in older adults

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

The commercial determinants of health

Germany must invest in its global health academic workforce

Helen Cox, Mark P Nicol The Lancet Infectious Diseases

Physical activity and prevention of type 2 diabetes

Long-term effects of hormone replacement therapy

Gareth L Ackland, Maurizio Cecconi, Rupert M Pearse

Political factors behind US global AIDS programmes slow-down

Charity begins at home in global health research funding

Threats to human health by great ocean garbage patches

Do air quality alerts benefit public health? New evidence from Canada

Gene therapy in haematology and oncology

Gene therapy—where are we?

Burden of obstetric fistula: from measurement to action

Effective cross-sector collaborations create sustainability

Volume 382, Issue 9906, Pages (November 2013)

A next-generation Alzheimer's centre for Madrid

Who is pirating medical literature

Arnaud Chiolero The Lancet Public Health

HIV myths should not be resuscitated

Pesticide self-poisoning: thinking outside the box

Malebona Precious Matsoso, Jeanette Rebecca Hunter, Vishal Brijlal

Effect of development assistance on domestic health expenditures

Comparing estimates of spending on health and HIV/AIDS

Food systems, nutrition, health and the environment

Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald

Volume 362, Pages s6-s7 (December 2003)

What would happen if we stopped vaccination?

Iran, sanctions, and research collaborations

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Person-centred maternity care in low-income and middle-income countries: analysis of data from Kenya, Ghana, and India Patience A Afulani, PhD, Beth.

Confessions of a journal junkie

Telling it like it isn't: truth and lies in a post-9/11 world

Elder abuse prevalence in community settings: a systematic review and meta-analysis Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,

Sufang Guo, Nuzhat Rafique, Danzhen You, Douglas J Noble

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries Dr Noreen.

Thank God for Richard Dawkins?

Low-technology approaches

Volume 393, Issue 10171, Pages e15-e16 (February 2019)

Thank you to our diverse (but not diverse enough) reviewers

Matthieu J Guitton The Lancet Planetary Health

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Costs of eliminating HIV in South Africa have been underestimated

GBD 2016 estimates problematic for South Africa

Spatial lifecourse epidemiology

How concentrated are academic publications of countries' progression towards universal health coverage? Adrian Gheorghe, Kalipso Chalkidou, Anthony Culyer

Stephen Allison, Tarun Bastiampillai, Doris A Fuller

A remarkable report card on progress in COPD

Jean H Humphrey, Andrew J Prendergast The Lancet Global Health

Difficulties of surgery in the developing world: a personal view

Political factors behind US global AIDS programmes slow-down

Volume 1, Issue 2, Pages (July 2014)

Guidance on research integrity: no union in Europe

Deriving a practical framework for the evaluation of health apps

Peng Jia, Youfa Wang The Lancet Global Health

Volume 18, Issue 5, Pages R198-R202 (March 2008)

Institutional challenges to achieving health equity in Ecuador

Symptom-based stratification of autoimmune diseases

Sickle cell disease: a new era

Autism, maths, and sex: the special triangle

Presentation transcript:

One more reason to fund the Global Fund Oliver Sabot, Shanelle Hall The Lancet Volume 379, Issue 9813, Pages e25-e26 (January 2012) DOI: 10.1016/S0140-6736(11)61756-X Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure Price and volume of artemether-lumefantrine in the public sector before and after the Global Fund and WHO actively facilitate the switch to ACTs ACTs=artemisinin-based combination therapies. In 2004, the Global Fund, working with WHO, provided many of its recipient countries with the impetus and financing necessary to rapidly change from suboptimal therapies (eg, chloroquine) to ACTs. The Lancet 2012 379, e25-e26DOI: (10.1016/S0140-6736(11)61756-X) Copyright © 2012 Elsevier Ltd Terms and Conditions